The Cochrane Library: Cochrane Database of Systematic Reviews

DOI: 10.1002/14651858

Reviews/Protocols listed by Cochrane Review Group

  1. Cochrane Acute Respiratory Infections Group
  2. Cochrane Airways Group
  3. Cochrane Anaesthesia, Critical and Emergency Care Group
  4. Cochrane Back and Neck Group
  5. Cochrane Bone, Joint and Muscle Trauma Group
  6. Cochrane Breast Cancer Group
  7. Cochrane Childhood Cancer Group
  8. Cochrane Colorectal Cancer Group
  9. Cochrane Common Mental Disorders Group
  10. Cochrane Consumers and Communication Group
  11. Cochrane Cystic Fibrosis and Genetic Disorders Group
  12. Cochrane Dementia and Cognitive Improvement Group
  13. Cochrane Developmental, Psychosocial and Learning Problems Group
  14. Cochrane Drugs and Alcohol Group
  15. Cochrane Effective Practice and Organisation of Care Group
  16. Cochrane ENT Group
  17. Cochrane Epilepsy Group
  18. Cochrane Eyes and Vision Group
  19. Cochrane Fertility Regulation Group
  20. Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group
  21. Cochrane Gynaecology and Fertility Group
  22. Cochrane Haematological Malignancies Group
  23. Cochrane Heart Group
  24. Cochrane Hepato-Biliary Group
  25. Cochrane HIV/AIDS Group
  26. Cochrane Hypertension Group
  27. Cochrane IBD Group
  28. Cochrane Incontinence Group
  29. Cochrane Infectious Diseases Group
  30. Cochrane Injuries Group
  31. Cochrane Kidney and Transplant Group
  32. Cochrane Lung Cancer Group
  33. Cochrane Metabolic and Endocrine Disorders Group
  34. Cochrane Methodology Review Group
  35. Cochrane Movement Disorders Group
  36. Cochrane Multiple Sclerosis and Rare Diseases of the CNS Group
  37. Cochrane Musculoskeletal Group
  38. Cochrane Neonatal Group
  39. Cochrane Neuromuscular Group
  40. Cochrane Oral Health Group
  41. Cochrane Pain, Palliative and Supportive Care Group
  42. Cochrane Pregnancy and Childbirth Group
  43. Cochrane Public Health Group
  44. Cochrane Schizophrenia Group
  45. Cochrane Skin Group
  46. Cochrane STI Group
  47. Cochrane Stroke Group
  48. Cochrane Tobacco Addiction Group
  49. Cochrane Upper GI and Pancreatic Diseases Group
  50. Cochrane Urology Group
  51. Cochrane Vascular Group
    1. About this group
    2. Reviews
      1. Aloe vera for prevention and treatment of infusion phlebitisReview
      2. Angioplasty versus bare metal stenting for superficial femoral artery lesionsReview
      3. Angioplasty (versus non surgical management) for intermittent claudicationReview
      4. Angioplasty versus stenting for iliac artery lesionsReview
      5. Angioplasty versus stenting for subclavian artery stenosisReview
      6. Ankle brachial index for the diagnosis of lower limb peripheral arterial diseaseReviewDiagnostic
      7. Anticoagulant treatment for subsegmental pulmonary embolismReview
      8. Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repairReview
      9. Anticoagulants (heparin, low molecular weight heparin and oral anticoagulants) for intermittent claudicationReview
      10. Anticoagulants versus non-steroidal anti-inflammatories or placebo for treatment of venous thromboembolismReview
      11. Antiplatelet agents for intermittent claudicationReview
      12. Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgeryReview
      13. Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatmentReview
      14. Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgeryReview
      15. Atherectomy for peripheral arterial diseaseReview
      16. Balloon angioplasty, with and without stenting, versus medical therapy for hypertensive patients with renal artery stenosisReview
      17. Beta-adrenergic blockers for perioperative cardiac risk reduction in people undergoing vascular surgeryReview
      18. Beta blockers for peripheral arterial diseaseReview
      19. Buflomedil for intermittent claudicationReview
      20. Bypass surgery for chronic lower limb ischaemiaReview
      21. Calcium channel blockers for primary Raynaud's phenomenonReview
      22. Cerebrospinal fluid drainage for thoracic and thoracoabdominal aortic aneurysm surgeryReview
      23. Chelation therapy for atherosclerotic cardiovascular diseaseReview
      24. CHIVA method for the treatment of chronic venous insufficiencyReview
      25. Cilostazol for intermittent claudicationReview
      26. Clinically-indicated replacement versus routine replacement of peripheral venous cathetersReview
      27. Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolismReview
      28. Compression stockings for preventing deep vein thrombosis in airline passengersReview
      29. Compression stockings for the initial treatment of varicose veins in patients without venous ulcerationReview
      30. Compression therapy for treating stage I and II (Widmer) post-thrombotic syndromeReview
      31. Continuous passive motion for preventing venous thromboembolism after total knee arthroplastyReview
      32. Controlled hypotension versus normotensive resuscitation strategy for people with ruptured abdominal aortic aneurysmReview
      33. Corticosteroids for the treatment of Kawasaki disease in childrenReview
      34. Cryoplasty for peripheral arterial diseaseReview
      35. D-dimer test for excluding the diagnosis of pulmonary embolismReviewDiagnostic
      36. Different types of intermittent pneumatic compression devices for preventing venous thromboembolism in patients after total hip replacementReview
      37. Different unfractionated heparin doses for preventing arterial thrombosis in children undergoing cardiac catheterizationReview
      38. Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacementReview
      39. Distal aortic perfusion during thoracoabdominal aneurysm repair for prevention of paraplegiaReview
      40. Dressings and topical agents for arterial leg ulcersReview
      41. Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for peripheral arterial disease of the lower limbsReview
      42. Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolismReview
      43. Effect of testing for cancer on cancer- and venous thromboembolism (VTE)-related mortality and morbidity in patients with unprovoked VTEReview
      44. Endovascular repair of abdominal aortic aneurysmReview
      45. Endovascular repair versus open repair for inflammatory abdominal aortic aneurysmsReview
      46. Endovascular stents for intermittent claudicationReview
      47. Endovascular treatment for ruptured abdominal aortic aneurysmReviewComment
      48. Endovascular versus conventional medical treatment for uncomplicated chronic type B aortic dissectionReview
      49. Endovascular versus open repair of asymptomatic popliteal artery aneurysmReview
      50. Endovenous ablation (radiofrequency and laser) and foam sclerotherapy versus open surgery for great saphenous vein varicesReview
      51. Endovenous ablation therapy (laser or radiofrequency) or foam sclerotherapy versus conventional surgical repair for short saphenous varicose veinsReview
      52. Exercise for intermittent claudicationReview
      53. Fibrinolytic agents for peripheral arterial occlusionReview
      54. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolismReview
      55. Garlic for peripheral arterial occlusive diseaseReview
      56. Ginkgo biloba for intermittent claudicationReview
      57. Graduated compression stockings for prevention of deep vein thrombosisReview
      58. Graft type for femoro-popliteal bypass surgeryReview
      59. Growth factors for angiogenesis in peripheral arterial diseaseReviewNew
      60. Heparin-bonded catheters for prolonging the patency of central venous catheters in childrenReview
      61. Heparin for the prevention of venous thromboembolism in acutely ill medical patients (excluding stroke and myocardial infarction)Review
      62. Heparin versus 0.9% sodium chloride intermittent flushing for prevention of occlusion in central venous catheters in adultsReview
      63. Heparin versus 0.9% sodium chloride intermittent flushing for the prevention of occlusion in long term central venous catheters in infants and childrenReview
      64. Home versus in-patient treatment for deep vein thrombosisReview
      65. Homocysteine lowering interventions for peripheral arterial disease and bypass graftsReview
      66. Horse chestnut seed extract for chronic venous insufficiencyReview
      67. Imaging for the exclusion of pulmonary embolism in pregnancyReviewDiagnostic
      68. Infusion techniques for peripheral arterial thrombolysisReview
      69. Injection sclerotherapy for varicose veinsReview
      70. Interposition vein cuff for infragenicular prosthetic bypass graftReview
      71. Interventions for implementation of thromboprophylaxis in hospitalized medical and surgical patients at risk for venous thromboembolismReview
      72. Interventions for preventing venous thromboembolism following abdominal aortic surgeryReview
      73. Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopyReview
      74. Intravascular brachytherapy for peripheral vascular diseaseReview
      75. Intravenous fluids for abdominal aortic surgeryReview
      76. Intravenous heparin during ruptured abdominal aortic aneurysmal repairReview
      77. Intravenous immunoglobulin as adjuvant therapy for Wegener's granulomatosisReview
      78. Intravenous immunoglobulin for the treatment of Kawasaki disease in childrenReview
      79. Intravenous naftidrofuryl for critical limb ischaemiaReview
      80. Knee length versus thigh length graduated compression stockings for prevention of deep vein thrombosis in postoperative surgical patientsReview
      81. Laparoscopic surgery for elective abdominal aortic aneurysm repairReviewNew
      82. Lipid-lowering for peripheral arterial disease of the lower limbReview
      83. Local intramuscular transplantation of autologous mononuclear cells for critical lower limb ischaemiaReview
      84. Low molecular weight heparin for prevention of central venous catheterization-related thrombosis in childrenReview
      85. Low molecular weight heparin for prevention of microvascular occlusion in digital replantation Review
      86. Low molecular weight heparin for prevention of venous thromboembolism in patients with lower-leg immobilizationReview
      87. Lumbar sympathectomy techniques for critical lower limb ischaemia due to non-reconstructable peripheral arterial diseaseReview
      88. Medical adjuvant treatment to increase patency of arteriovenous fistulae and graftsReview
      89. Medical treatment for small abdominal aortic aneurysmsReview
      90. Modes of exercise training for intermittent claudicationReview
      91. Naftidrofuryl for intermittent claudicationReview
      92. Non-pharmaceutical measures for prevention of post-thrombotic syndromeReview
      93. Non-pharmacological interventions for preventing venous insufficiency in a standing worker populationReview
      94. Omega-3 fatty acids for intermittent claudicationReview
      95. Once versus twice daily low molecular weight heparin for the initial treatment of venous thromboembolismReview
      96. Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of deep vein thrombosisReview
      97. Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of pulmonary embolismReview
      98. Oral vasodilators for primary Raynaud's phenomenonReview
      99. Outpatient versus inpatient treatment for acute pulmonary embolismReview
      100. Padma 28 for intermittent claudicationReview
      101. Pentasaccharides for the prevention of venous thromboembolismReview
      102. Pentoxifylline for intermittent claudicationReview
      103. Pharmacological treatment for Buerger's diseaseReview
      104. Pharmacological treatment of vascular risk factors for reducing mortality and cardiovascular events in patients with abdominal aortic aneurysmReview
      105. Pharmacomechanical thrombectomy for iliofemoral deep vein thrombosisReview
      106. Phlebotonics for venous insufficiencyReview
      107. Physical exercise for the treatment of non-ulcerated chronic venous insufficiencyReview
      108. Prevention of infection in arterial reconstructionReview
      109. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapyReview
      110. Primary prophylaxis for venous thromboembolism in patients undergoing cardiac or thoracic surgeryReview
      111. Primary prophylaxis for venous thromboembolism in people undergoing major amputation of the lower extremityReview
      112. Prostanoids for critical limb ischaemiaReview
      113. Prostanoids for intermittent claudicationReview
      114. Prosthetic rehabilitation for older dysvascular people following a unilateral transfemoral amputationReview
      115. Remote ischaemic preconditioning versus no remote ischaemic preconditioning for vascular and endovascular surgical proceduresReview
      116. Revascularisation of the left subclavian artery for thoracic endovascular aortic repairReview
      117. Rutosides for prevention of post-thrombotic syndromeReview
      118. Rutosides for treatment of post-thrombotic syndromeReview
      119. Salicylate for the treatment of Kawasaki disease in childrenReview
      120. Sclerotherapy for lower limb telangiectasiasReview
      121. Screening for abdominal aortic aneurysmReview
      122. Screening for peripheral arterial diseaseReview
      123. Slow versus fast subcutaneous heparin injections for prevention of bruising and site-pain intensityReview
      124. Spinal cord stimulation for non-reconstructable chronic critical leg ischaemiaReview
      125. Statins for primary prevention of venous thromboembolismReview
      126. Stent graft types for endovascular repair of abdominal aortic aneurysmsReview
      127. Stent graft types for endovascular repair of thoracic aortic aneurysmsReview
      128. Stent placement versus surgery for coarctation of the thoracic aortaReview
      129. Steroid sex hormones for lower limb atherosclerosisReview
      130. Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolismReview
      131. Subintimal angioplasty for lower limb arterial chronic total occlusionsReview
      132. Supervised exercise therapy versus non-supervised exercise therapy for intermittent claudicationReview
      133. Surgery for deep venous incompetenceReview
      134. Surgery for small asymptomatic abdominal aortic aneurysmsReview
      135. Surgery for varicose veins: use of tourniquetReview
      136. Surgery versus sclerotherapy for the treatment of varicose veinsReview
      137. Surgery versus thrombolysis for initial management of acute limb ischaemiaReview
      138. Thoracic endovascular repair (TEVAR) versus open surgery for blunt traumatic thoracic aortic injuryReview
      139. Thoracic stent graft versus surgery for thoracic aneurysmReview
      140. Thrombolysis for acute deep vein thrombosisReview
      141. Thrombolytic therapy for pulmonary embolismReview
      142. Thrombophilia testing for prevention of recurrent venous thromboembolismReview
      143. Totally percutaneous versus surgical cut-down femoral artery access for elective bifurcated abdominal endovascular aneurysm repairReview
      144. Transperitoneal versus retroperitoneal approach for elective open abdominal aortic aneurysm repairReview
      145. Treatment for femoral pseudoaneurysmsReview
      146. Treatment for superficial infusion thrombophlebitis of the upper extremityReview
      147. Treatment for superficial thrombophlebitis of the legReview
      148. Treatment of hypertension in peripheral arterial diseaseReview
      149. Type of incision for below knee amputationReview
      150. Ultrasonography for endoleak detection after endoluminal abdominal aortic aneurysm repairReviewDiagnosticNew
      151. Unfractionated heparin versus low molecular weight heparins for avoiding heparin-induced thrombocytopenia in postoperative patientsReview
      152. Vascular closure devices for femoral arterial puncture site haemostasisReview
      153. Vena caval filters for the prevention of pulmonary embolismReview
      154. Venous cutdown versus the Seldinger technique for placement of totally implantable venous access portsReview
      155. Vitamin E for intermittent claudicationReview
      156. Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolismReview
      157. Warfarin initiation nomograms for venous thromboembolismReview
    3. Protocols
      1. Anatomical iliofemoral bypass versus extra-anatomical crossover grafting for symptomatic unilateral iliac diseaseProtocol
      2. Angioplasty and stenting for peripheral arterial disease of the lower limbs: an overview of Cochrane ReviewsProtocolOverview
      3. Angioplasty for deep venous thrombosisProtocol
      4. Antiplatelet agents for the treatment of deep venous thrombosisProtocol
      5. Antiplatelet and anticoagulant agents for preventing recurrence of peripheral vascular thrombosis in patients with Antiphospholipid syndromeProtocol
      6. Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid antibodiesProtocol
      7. Autologous versus prosthetic arteriovenous fistulae for vascular accessProtocolWithdrawn
      8. D-Dimer tests for the diagnosis of deep venous thrombosis in symptomatic hospital outpatients with a clinical prediction ruleProtocolDiagnostic
      9. Different sources of autologous mononuclear cells and stem cells for critical lower limb ischaemiaProtocol
      10. Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repairProtocol
      11. Disease management interventions for improving self-management in lower-limb peripheral arterial diseaseProtocol
      12. Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for the treatment of in-stent restenosis of the femoropopliteal arteriesProtocol
      13. Duplex ultrasound for the detection of stenosis after peripheral arterial bypass grafting using autologous veinProtocolDiagnostic
      14. Duplex ultrasound for the diagnosis of symptomatic deep vein thrombosis in the lower limbProtocolDiagnostic
      15. Endoluminal stents for iliac and infrainguinal arterial diseaseProtocol
      16. Endovascular revascularisation versus conservative management for intermittent claudicationProtocol
      17. Endovascular versus conventional medical treatment for uncomplicated acute type B aortic dissectionProtocol
      18. Fast track surgery programmes for abdominal aortic aneurysm surgeryProtocol
      19. Gene therapy for peripheral arterial diseaseProtocol
      20. Gene therapy for peripheral arterial diseaseProtocolWithdrawn
      21. General versus loco-regional anaesthesia for endovascular aneurysm repairProtocolWithdrawn
      22. Graft type for open abdominal aortic surgeryProtocol
      23. Heparin dose for thrombosis prophylaxis during peripheral vascular angioplastyProtocol
      24. Lumbar sympathectomy versus prostanoids for critical limb ischaemia due to non-reconstructable peripheral arterial diseaseProtocol
      25. Neuromuscular electrical stimulation for the prevention of venous thromboembolismProtocol
      26. Operative technique for the treatment of popliteal artery aneurysmsProtocol
      27. Pentasaccharides for the treatment of deep vein thrombosisProtocol
      28. Pentoxifylline for critical limb ischaemiaProtocol
      29. Percutaneous transluminal arterial angioplasty versus stenting for infrapopliteal arterial lesions in critical limb ischaemiaProtocol
      30. Pharmacological anticoagulation and mechanical compression versus mechanical compression alone for venous thromboembolism prophylaxis for post-operative neurosurgical patientsProtocol
      31. Physiotherapeutic mechanisms for prevention of deep vein thrombosis in patients at risk of haemorrhageProtocolWithdrawn
      32. Positron emission tomography (PET) for the detection of vascular graft infectionsProtocolDiagnostic
      33. Propionyl-L-carnitine for intermittent claudicationProtocol
      34. Sarpogrelate for peripheral arterial diseaseProtocol
      35. Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolismProtocol
      36. Thrombolysis for acute upper extremity deep vein thrombosisProtocol
      37. TNF-α blockers for the treatment of Kawasaki disease in childrenProtocol
      38. Ultrasonography for clinically suspected upper extremity deep vein thrombosisProtocolDiagnostic
  52. Cochrane Work Group
  53. Cochrane Wounds Group